The European Medicines Agency is inviting stakeholder feedback on a draft guideline that explains how sponsors can protect personal data and commercially confidential information that they submit to the new EU Clinical Trials Information System (CTIS).
The guideline is in response to new transparency obligations introduced by the Clinical Trial Regulation (CTR), which came into force...